MBRP on Reducing Craving and Addictive Behaviour in Adults
The Feasibility and Effects of Mindfulness Based Relapse Prevention (MBRP) on Reducing Craving and Addictive Behaviour in Adults With Substance Abuse Disorders
1 other identifier
interventional
80
1 country
9
Brief Summary
Mindfulness-base interventions are promising interventions as an adjunctive therapy to be integrated into current existing anti-drug services. The advantages of MBRP can include: 1) having very low stigma as mindfulness courses are already widely accepted and used among different populations including healthy populations. The running of mindfulness courses can be more acceptable by the community; 2) it could be more accessible and cost-effective as it can be provided in group and in community settings; 3) it is a skill that can be learned and be used after the 8 week course , e.g. when the drug user is triggered in unforeseen circumstances, they may apply the learnt mindfulness skills to help themselves overcome the difficulties when timely professional help is not available; 4) Drug Abuse Statistics from Narcotics Division, Security Bureau of the government of Hong Kong showed that the most common reasons for recurrent drug use were to avoid discomfort of its absence (62%) and relief of depression/stress/boredom (30%). The study objectives are as follow:
- 1.To evaluate the feasibility of using mindfulness- based relapse prevention (MBRP) programme among adults with substance abuse in Hong Kong;
- 2.To examine the changes of craving, substance use, mood symptoms, self-efficacy, acceptance, level of mindfulness and quality of life between those who have enrolled in the MBRP as compared to those in the usual care control group;
- 3.To evaluate the correlations between changes in substance use and craving and changes in mood symptoms, self-efficacy, acceptance, level of mindfulness, and quality of life; and
- 4.To study participants' characteristics related to adherence and benefits associated with MBRP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2019
CompletedFirst Posted
Study publicly available on registry
July 26, 2019
CompletedStudy Start
First participant enrolled
August 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedFebruary 7, 2024
February 1, 2024
4.5 years
July 18, 2019
February 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Self report of any drug abuse and usage
Self-reports of no substance use to confirm abstinence status
Post intervention (after 8 weeks of intervnetion from baseline)
Urine drug test (also known as Urine drug screen or UDS)
Urine test for the presence of illegal drugs and prescription medications
Post intervention (after 8 weeks of intervnetion from baseline)
Secondary Outcomes (11)
The Penn Alcohol Craving Scale
baseline, post intervention (after 8 weeks of intervnetion from baseline), 3 months post intervention, 6 months post intervention, 9 months post intervention and 12 months post intervention
the 9-item Patient Health Questionnaire (PHQ-9)
baseline, post intervention (after 8 weeks of intervnetion from baseline), 3 months post intervention, 6 months post intervention, 9 months post intervention and 12 months post intervention
the 7-item Generalised Anxiety Disorder (GAD-7)
baseline, post intervention (after 8 weeks of intervnetion from baseline), 3 months post intervention, 6 months post intervention, 9 months post intervention and 12 months post intervention
The Addiction Severity Index (ASI) - Lite Version
baseline, post intervention (after 8 weeks of intervnetion from baseline), 3 months post intervention, 6 months post intervention, 9 months post intervention and 12 months post intervention
Drug Avoidance Self-Efficacy Scale
baseline, post intervention (after 8 weeks of intervnetion from baseline), 3 months post intervention, 6 months post intervention, 9 months post intervention and 12 months post intervention
- +6 more secondary outcomes
Study Arms (2)
Mindfulness-based Relapses Prevention (MBRP)
EXPERIMENTALThe MBRP program will be delivered by an instructor with training in MBSR/MBCT who has more than two years of teaching experience in MBSR/MBCT. The MBRP programme will consist of 2.5 hour weekly sessions for 8 weeks. The mindfulness curriculum will include training in mindfulness through (1) a body scan, (2) sitting meditation and (3) mindful stretching exercises.
Usual Care Control Group (UCCG)
ACTIVE COMPARATORParticipants in the UCCG condition will remain in their standard outpatient aftercare provided by the treatment agency with an aim to maintain their abstinence with the help from social workers or other healthcare professionals through different activities, such as topics on life training skills such as rational thinking skills, grief and loss, assertiveness, self esteem, goal setting, effects of drugs on interpersonal relationships and experience. Frequency of their visits to / contacts with healthcare professionals will be recorded.
Interventions
Manualized MBRP program is used with a central theme in each session, with meditation practices and relapse prevention exercises and discussions. Themes include the concept of "automatic pilot" and its relationship to addiction relapse, recognizing thoughts and emotions in relation to triggers of relapse, integrating mindfulness practices into daily activities, practicing mindfulness in high risk situations and the role of thoughts and emotions in relapse. Include daily homework exercises that consist of awareness exercises directed at increasing non-judgmental awareness of bodily sensations, thoughts and feelings, together with exercises designed to integrate awareness skills into daily life. Include training in mindfulness through body scan, sitting meditation, and mindful stretching exercises, to cultivate awareness during simple stretching movement.
Participants in the UCCG condition will remain in their standard outpatient aftercare provided by the treatment agency with an aim to maintain their abstinence with the help from social workers or other healthcare professionals through different activities, such as topics on life training skills such as rational thinking skills, grief and loss, assertiveness, self esteem, goal setting, effects of drugs on interpersonal relationships and experience. Frequency of their visits to / contacts with healthcare professionals will be recorded.
Eligibility Criteria
You may qualify if:
- Fluent in Cantonese;
- Has ever fulfilled the Structured Clinical Interview for DSM-IV/DSM-5 (SCID) drug module criteria for substance use disorder diagnoses; and
- Has completed outpatient or inpatient treatment for substance abuse in the previous 6 months.
You may not qualify if:
- Inability to provide valid consent;
- Current or lifetime psychotic disorder assessed by the Structured Clinical interview for DSM-IV/DSM-5;
- Imminent suicidal risk; or
- Dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Department of Psychiatry, AHNH, Hospital Authority
Hong Kong, Hong Kong
Department of Psychiatry, NDH, Hospital Authority
Hong Kong, Hong Kong
Evergreen Lutheran Centre, Hong Kong Lutheran Social Service
Hong Kong, Hong Kong
Neo-Health Group
Hong Kong, Hong Kong
PS33 - Shamshuipo Centre, Hong Kong Christian Service
Hong Kong, Hong Kong
Rainbow Lutheran Centre, Hong Kong Lutheran Social Service
Hong Kong, Hong Kong
Sane Centre
Hong Kong, Hong Kong
The Society of Rehabilitation and Crime Prevention, Oasis
Hong Kong, Hong Kong
TWGHs CROSS Centre
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel YS Wong
JCSPHPC, CUHK
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- In this open-label study, blinding of therapists and participants will not be possible. However, all data collection will be performed by a trained research assistant blinded to the allocation status of the participants. The research assistant will receive rigorous training in standardized data collection procedures. Data entry will be prepared so that the person can conduct the statistical analyses without referring to allocation information, thus ensuring blinding during data analysis.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
July 18, 2019
First Posted
July 26, 2019
Study Start
August 15, 2019
Primary Completion
January 31, 2024
Study Completion
August 31, 2024
Last Updated
February 7, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share